LexisConferences is delighted to invite all to the upcoming World Biosimilars & Biologics Summit 2019 which is going to be held on March 27-28, 2020 at Newyork, USA.
Biosimilars Summit 2020 is a phenomenal event which will be bringing together people from different domains of pharmaceutical and biopharmaceutical world such as Researchers, Analysts, Pharmacists, Pharmacovigilants, Regulatory and IPR Attorneys, Business Development Teams, Professors, PhD research scholars and more to discuss on the topics related to Biosimilars and Biologics. This international event also includes Keynote talks, Plenary sessions, Young Investigators Forum, Special Sessions, Panel Discussions, Exhibitions, Poster Presentations, Workshop and Symposiums.
Biosimilars Summit 2020 aims at providing opportunities to all its Speakers and Delegates to come together to interact and exchange new ideas related to biosimilars, biologics, biopharmaceuticals and more. This conference will provide all our participants Business 2 Business sessions, where they will be able to reach out and make a mark for themselves globally.
The Global biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 4.49 Billion in 2017, at a CAGR of 31.7%. By far European Countries dominate the market owing to the favorable government regulations in this region representing 80% of global spending followed by USA which approximately covers around 50% global biologics market and coming to Asia it is expected that in the next 5 years global pharmaceutical spending will rise upto 43% from a roughly 38%.